These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19951286)

  • 1. Therapy with nonglycosaminoglycan-binding mutant CCL7: a novel strategy to limit allograft inflammation.
    Ali S; O'Boyle G; Hepplewhite P; Tyler JR; Robertson H; Kirby JA
    Am J Transplant; 2010 Jan; 10(1):47-58. PubMed ID: 19951286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation.
    Ali S; Robertson H; Wain JH; Isaacs JD; Malik G; Kirby JA
    J Immunol; 2005 Jul; 175(2):1257-66. PubMed ID: 16002730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
    Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
    PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
    Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
    Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft.
    Jiankuo M; Xingbing W; Baojun H; Xiongwin W; Zhuoya L; Ping X; Yong X; Anting L; Chunsong H; Feili G; Jinquan T
    J Immunol; 2003 Feb; 170(3):1556-65. PubMed ID: 12538721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of male-specific minor histocompatibility antigen H-Y in epidermal equivalent allograft rejection.
    Beaulieu MJ; Li H; Bergeron J; Ross G; Auger FA; Rouabhia M
    Cell Transplant; 1998; 7(1):11-23. PubMed ID: 9489759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts.
    Watarai Y; Koga S; Paolone DR; Engeman TM; Tannenbaum C; Hamilton TA; Fairchild RL
    J Immunol; 2000 Jun; 164(11):6027-33. PubMed ID: 10820287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts.
    Kobayashi H; Novick AC; Toma H; Fairchild RL
    Transplantation; 2002 Aug; 74(3):387-95. PubMed ID: 12177619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple glycosaminoglycan-binding epitopes of monocyte chemoattractant protein-3/CCL7 enable it to function as a non-oligomerizing chemokine.
    Salanga CL; Dyer DP; Kiselar JG; Gupta S; Chance MR; Handel TM
    J Biol Chem; 2014 May; 289(21):14896-912. PubMed ID: 24727473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig.
    Koga S; Auerbach MB; Engeman TM; Novick AC; Toma H; Fairchild RL
    J Immunol; 1999 Nov; 163(9):4878-85. PubMed ID: 10528189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CCL25 antibody prolongs skin allograft survival by blocking CCR9 expression and impairing splenic T-cell function.
    Li J; Xiong T; Xiao R; Xiong A; Chen J; Altaf E; Zheng Y; Zhu G; He Y; Tan J
    Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):237-44. PubMed ID: 23456208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
    Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
    Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.
    Zhang Z; Kaptanoglu L; Haddad W; Ivancic D; Alnadjim Z; Hurst S; Tishler D; Luster AD; Barrett TA; Fryer J
    J Immunol; 2002 Apr; 168(7):3205-12. PubMed ID: 11907073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
    Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
    J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
    Solomon MF; Kuziel WA; Simeonovic CJ
    Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-derived IP-10 initiates development of acute allograft rejection.
    Hancock WW; Gao W; Csizmadia V; Faia KL; Shemmeri N; Luster AD
    J Exp Med; 2001 Apr; 193(8):975-80. PubMed ID: 11304558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
    Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
    J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression.
    Benghiat FS; Graca L; Braun MY; Detienne S; Moore F; Buonocore S; Flamand V; Waldmann H; Goldman M; Le Moine A
    Transplantation; 2005 Mar; 79(6):648-54. PubMed ID: 15785370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.